Xencor (XNCR) Total Liabilities (2013 - 2026)
Xencor (XNCR) posted quarterly Total Liabilities of $221.2 million for Q1 2026, down 16.47% year-over-year from $264.8 million in Q1 2025, and down 7.79% quarter-over-quarter from $239.9 million in Q4 2025.
Analysis
Xencor (XNCR) Total Liabilities (2013 - 2026) Analysis & Trends
Xencor (XNCR) has reported Total Liabilities for 14 consecutive years, with $221.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Liabilities fell 16.47% year-over-year to $221.2 million; the TTM figure through Mar 2026 stood at $221.2 million (down 16.47% YoY), while the FY2025 annual figure was $239.9 million, down 13.68% from the prior year.
- Total Liabilities eased to $221.2 million in Q1 2026 per XNCR's latest filing, from $239.9 million in the prior quarter.
- Across five years, Total Liabilities topped out at $303.0 million in Q4 2023 and bottomed at $94.9 million in Q1 2022.
- Historically, Total Liabilities has averaged $203.3 million across 5 years, with a median of $239.9 million in 2025.
- Annual changes were most pronounced in 2024 — Total Liabilities soared 194.13% — and 2025, when it dropped 17.17%.
- Xencor's Total Liabilities stood at $118.8 million in 2022, then jumped by 155.16% to $303.0 million in 2023, then dropped by 8.29% to $277.9 million in 2024, then slipped by 13.68% to $239.9 million in 2025, then declined by 7.79% to $221.2 million in 2026.
- Business Quant data shows XNCR's Total Liabilities at $221.2 million in Q1 2026, $239.9 million in Q4 2025, and $243.5 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 4.20 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 1.72 Bn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 4.00 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 4.20 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 10.03 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Xencor | 2.02 Bn | 1.65 Bn | - | 221.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 221.73 Mn |
| Mar 31, 2026 | 221.21 Mn |
| Dec 31, 2025 | 239.91 Mn |
| Sep 30, 2025 | 243.50 Mn |
| Jun 30, 2025 | 259.07 Mn |
| Mar 31, 2025 | 264.82 Mn |
| Dec 31, 2024 | 277.92 Mn |
| Sep 30, 2024 | 293.98 Mn |
| Jun 30, 2024 | 291.91 Mn |
| Mar 31, 2024 | 297.12 Mn |
| Dec 31, 2023 | 303.05 Mn |
| Sep 30, 2023 | 109.42 Mn |
| Jun 30, 2023 | 99.25 Mn |
| Mar 31, 2023 | 119.83 Mn |
| Dec 31, 2022 | 118.77 Mn |
| Sep 30, 2022 | 112.57 Mn |
| Jun 30, 2022 | 108.98 Mn |
| Mar 31, 2022 | 94.90 Mn |
| Dec 31, 2021 | 104.71 Mn |
| Sep 30, 2021 | 78.40 Mn |